Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Consolidated financial results for the year ended March 31, 2026 (FY2025)
May 13, 2026
|
In
Reports
|
By
JCR Pharmaceuticals
Download PDF
Back to Newsroom
Privacy Preference Center
Privacy Preferences